The implementation of CMS’ new clinical lab payment rates in Medicare could increase costs by $11 billion between 2018 and 2020, according to a new report from the Government Accountability Office.
A new MedPAC report to Congress concludes there is evidence that "access to services can be maintained with lower rates" to labs like Quest Diagnostics and LabCorp and advised policymakers to take ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results